These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 18166309

  • 1. Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
    Thomas W, Seidenspinner S, Kawczyńska-Leda N, Kramer BW, Chmielnicka-Kopaczyk M, Marx A, Szymankiewicz M, Speer CP.
    Am J Obstet Gynecol; 2008 Jan; 198(1):64.e1-6. PubMed ID: 18166309
    [Abstract] [Full Text] [Related]

  • 2. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD.
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [Abstract] [Full Text] [Related]

  • 3. Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus?
    Holcroft CJ, Askin FB, Patra A, Allen MC, Blakemore KJ, Graham EM.
    Am J Obstet Gynecol; 2004 Dec; 191(6):2010-5. PubMed ID: 15592284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia.
    Oue S, Hiroi M, Ogawa S, Hira S, Hasegawa M, Yamaoka S, Yasui M, Tamai H, Ogihara T.
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F17-22. PubMed ID: 18676413
    [Abstract] [Full Text] [Related]

  • 8. Chorioamnionitis/funisitis and the development of bronchopulmonary dysplasia.
    Kent A, Dahlstrom JE.
    J Paediatr Child Health; 2004 Jul; 40(7):356-9. PubMed ID: 15228562
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants.
    Zanardo V, Vedovato S, Trevisanuto DD, Suppiej A, Cosmi E, Fais GF, Chiarelli S.
    Hum Pathol; 2006 Jan; 37(1):87-91. PubMed ID: 16360420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia.
    Prencipe G, Auriti C, Inglese R, Devito R, Ronchetti MP, Seganti G, Ravà L, Orzalesi M, De Benedetti F.
    Pediatr Res; 2011 Feb; 69(2):142-7. PubMed ID: 21045753
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops.
    Watterberg KL, Demers LM, Scott SM, Murphy S.
    Pediatrics; 1996 Feb; 97(2):210-5. PubMed ID: 8584379
    [Abstract] [Full Text] [Related]

  • 18. Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia.
    Zimmerman JJ, Gabbert D, Shivpuri C, Kayata S, Ciesielski W, Miller J, Peters ME, Eissenstat RP, Shen G.
    Am J Perinatol; 1998 Feb; 15(10):567-76. PubMed ID: 9926878
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development.
    Janér J, Andersson S, Haglund C, Karikoski R, Lassus P.
    Pediatrics; 2008 Aug; 122(2):340-6. PubMed ID: 18676552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.